Implementation Brief: Understanding access issues for new therapies

Eric NormanFoCUS, Research Briefs

Thumbnail image of the implementation brief

Our first implementation brief outlines several major barriers to patient access for novel cell and gene therapies. It also describes how providers, payers, and developers may overcome these barriers, with a focus on addressing these challenges for the new sickle cell disease (SCD) therapies, Casgevy and Lyfgenia. ​

NEWDIGS Implementation Brief Access Issues.pdf

Share the research